Biotech chief lashes hedge fund's patent trolling By: CNBC.com News September 19, 2015 at 16:13 PM EDT Hedge fund heavyweight Kyle Bass has placed a big bet in biotech but one CEO is defending his company against the activist's claims. Read More >> Related Stocks: Acorda Therapeutics